1. Home
  2. SHPH

SHPH

Shuttle Pharmaceuticals Holdings Inc.

Logo Shuttle Pharmaceuticals Holdings Inc.

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

as 04-12-2024 4:00pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Shuttle Pharmaceuticals Holdings Inc is a clinical stage pharmaceutical company leveraging our proprietary technology to develop novel therapies designed to cure cancers. The company's goal is to extend the benefits of cancer treatments by leveraging insights into the pillars of cancer therapy: surgery, radiation therapy, chemotherapy, and immunotherapy.

Founded: 2012 Country:
United States
United States
Employees: N/A City: GAITHERSBURG
Market Cap: 6.8M IPO Year: 2022
Target Price: N/A AVG Volume (30 days): 119.5K
Analyst Decision: N/A Number of Analysts: N/A
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -0.44 EPS Growth: N/A
52 Week Low/High: $0.35 - $2.75 Next Earning Date: 05-23-2024
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

Share on Social Networks: